ClinicalTrialsFinder

Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma Clinical Trials in Pittsburgh, Pennsylvania

1 recruitingPittsburgh, Pennsylvania

Showing 1–1 of 1 trials

Recruiting
Phase 1

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

Metastatic Malignant Solid NeoplasmUnresectable Malignant Solid NeoplasmPlatinum-Resistant Ovarian High Grade Serous Adenocarcinoma
National Cancer Institute (NCI)55 enrolled7 locationsNCT04585958